RESEARCHER PROFILE
Professor Alice Rumbold (Filmed November 2023)
Perinatal epidemiologist & Co-Theme Leader of
SAHMRI Women and Kids
South Australian Health and Medical Research Institute &
Research Leader, Robinson Research Institute
University of Adelaide
Adelaide, Australia
Professor Alice Rumbold is Theme Leader of SAHMRI Women and Kids, managing a multidisciplinary research team focussed on improving health outcomes for women, babies and families. She also holds an affiliate position as a Research Leader within the Robinson Research Institute at the University of Adelaide.
An epidemiologist and health services researcher, she is internationally renowned for her leadership of large-scale clinical trials, epidemiological studies and systematic review activities to improve perinatal and reproductive health care. She is passionate about improving health outcomes for women and babies, particularly those experiencing vulnerability. Her current research interests include preterm birth, breastfeeding, human milk banking and infertility.
She has held continuous NHMRC funding as a CI since 2007, totalling >$21.2m across 13 grants, including a NHMRC Career Development Fellowship. Her research has generated significant publications in top-ranking journals such as the New England Journal of Medicine, Lancet Global Health, British Journal of Obstetrics and Gynaecology, Human Reproduction and American Journal of Epidemiology, including 11 papers with over 100 citations.
Professor Rumbold’s current research is primarily focused on improving breastfeeding outcomes in preterm babies. She runs several clinical trials that aim to improve breastfeeding outcomes in premature babies, a vulnerable group that is known to have difficulties with establishing breastfeeding. Alice’s research tests new interventions to improve breastfeeding outcomes in these babies, as breast milk is particularly crucial for their development.
Professor Rumbold finds motivation and inspiration from the families participating in her research. These families often participate while knowing that they may not receive direct benefits from the research. She is also driven by the potential to have lifelong impacts on health and opportunities by improving outcomes in the early months of life.
Apart from research, Professor Rumbold loves music. She enjoys listening to it, playing it, and attending live music events. She is a keen cellist and pianist and was previously involved with the Darwin Symphony Orchestra.
You Might also like
-
Behavioural science in cancer screening, control and communication
Dr Dodd has an established international reputation as a behavioural scientist in cancer control and communication. Since completing her PhD in 2016, Dr Dodd has been awarded a three-year University of Sydney Postdoctoral Research Fellowship (2018-2021) and a three-year Research Fellowship at The Daffodil Centre (current). Dr Dodd is the co-chair of the ‘Strengthening and optimising approaches to cancer prevention, screening, and early detection’ hub at The Daffodil Centre (with more than 130 staff and students).
-
Benefits of prehabilitation ahead of surgery
Dr Matthew Wallen PhD, AES, AEP is a Senior Research Fellow in Cancer Survivorship, the Deputy Lead of the Cancer Survivorship Program, and a Senior Lecturer in Exercise Science and Clinical Exercise Physiology within the College of Nursing and Health Sciences at Flinders University, in South Australia. His clinical interest focuses on improving outcomes for people requiring major surgery, specifically (1) lifestyle interventions, including exercise, nutritional, and psychological support to improve the health and wellbeing of people prior to surgery, termed ‘prehabilitation’, (2) novel physical function assessments aimed at identifying people at risk of treatment-related complications, and (3) implementation of new models of care in cancer.
-
Superslayer taking on antibiotic-resistant bacteria
Dr Katharina Richter is a visionary leader in MedTech, acclaimed for innovation and gender diversity. With over 40 awards to her name, including MIT Innovator Under 35 Asia-Pacific, and Prime Minister’s Prize for New Innovator finalist, she has shattered barriers as an entrepreneur, scientist, and ‘superbug slayer.’ Katharina’s groundbreaking work in combating antibiotic-resistant bacteria has resulted in 6 innovative treatments, 3 of which are patented, offering hope against deadly infections.